vimarsana.com
Home
Live Updates
Amarin Highlights New Data Providing Potential Mechanistic I
Amarin Highlights New Data Providing Potential Mechanistic I
Amarin Highlights New Data Providing Potential Mechanistic Insight into Vascepa®/Vazkepa® (Icosapent Ethyl) Reduction of Cardiovascular Events
— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — --Data Further Advances Understanding of VASCEPA/VAZKEPA... | May 12, 2023
Related Keywords
Ireland ,
United Arab Emirates ,
Canada ,
United States ,
New Jersey ,
Switzerland ,
Boston ,
Massachusetts ,
Leipsic ,
Offaly ,
Chicago ,
Illinois ,
Loyola University ,
Dublin ,
Lebanon ,
Finland ,
Sweden ,
American ,
Clin Cardiol ,
Nabil Abadir ,
Farouc Jaffer ,
Lisa Defrancesco ,
Mohamad Kassab ,
Markg Rabbat ,
Mark Marmur ,
Coll Cardiol ,
Drug Administration ,
Corporate Communications ,
Head Of Global Medical Affairs ,
Research Demonstrates Multifactorial Beneficial ,
A Report From The American Heart Association ,
Amarin Corporation ,
Amarin Pharmaceuticals Ireland ,
Journal Of The American College Cardiology ,
Nasdaq ,
American Heart Association ,
Exchange Commission ,
European Union ,
American Heart Association Vascular Discovery ,
Investor Relations Amarin Corporation ,
Coronary Physiology ,
Plaque Progression ,
Data Further Advances Understanding ,
European Heart Journal ,
Vascular Discovery ,
Icosapent Ethyl ,
Coronary Physiology Assessed ,
Cardiac Computed Tomography ,
Vivo Atheroma Progression ,
Inflammatory Protease ,
Chronic Total Occlusion ,
Chief Medical Officer ,
Global Medical Affairs ,
New England Journal ,
American College ,
United Arab ,
Safety Information ,
Product Characteristics ,
Private Securities Litigation Reform Act ,
Securities Act ,
Relations Amarin Corporation ,
Heartj Cardiovasc ,
Flow Reserve Derived ,
Stable Coronary Artery ,
Year Impact ,
Medical Practice ,
Clinical Outcomes ,
Heart Disease ,
Stroke Statistics ,
Report From ,
American Heart ,
Cardiovascular Events ,
Cardiovascular Risk Reduction ,
Total Ischemic Events ,
Amarin Corporation Plc Stock Exchange ,
News ,
Information ,
Press Release ,
Few ,
Research ,
Emonstrates ,
Multifactorial ,
Fbeneficial ,
Effects ,
F ,
N ,
Coronary ,
Hysiology ,
End ,
Plaque ,
Progression ,
Urther ,
Advances ,
Understanding ,
F Amrn Us0231112063 ,